We deduced that Agkistrodon actus venom serine proteinases I and II, previously isolated from the venom of A. acutus (Zhu, Z., Gong, P., Teng, M., and Niu, L. (2003 The information derived from the three-dimensional structures of snake venom serine proteinases (SV-SPs) 1 remains of concern, because of the medical interest of venomosalivary serine proteinases. Most biochemical properties, biological roles, and structure of SV-SPs are mainly characterized by using TSV-PA, a plasminogen activator from Trimeresurus stejnegeri venom, with the structure of SV-SPs as the only available model (2-7). Wide variance of the sequences and enzymatic properties of these proteinases, which is the feature of SV-SPs (8, 9), requires more structural models to annotate the detailed relationship. In particular, although the carbohydrates in native TSV-PA were documented to have little influence on its amidolytic activity and plasminogen activation property (3, 4), most of SV-SPs contain carbohydrates at variant glycosylation sites, which tempts us to explore whether all of these proteinases match TSV-PA.We have reported previously the purification, partial characterization, and crystallization of two glycosylated SV-SPs, AaV-SP-I and AaV-SP-II from the venom of Agkistrodon acutus (1). Both proteinases have the activity of esterolysis and fibrin-(ogen)olysis and share the same N-terminal amino acid sequence. The proteolytic and esterolytic activities of the proteinases could not be inhibited by some natural serine proteinase inhibitors (e.g. soybean trypsin inhibitor (SBTI)). Both proteinases have a postulated glycosylated site at Asn35, but the proportions of the carbohydrates within the two proteinases are different (i.e. ϳ9% for AaV-SP-I and ϳ4% for AaV-SP-II, respectively). In this study, we analyzed the entire amino acid sequences of the two proteinases and determined their threedimensional structures and the linked oligosaccharide components. Structural comparison revealed that oligosaccharides in the two proteinases provide spatial hindrance toward the binding of some natural inhibitors and might be involved in the enzyme-inhibitor interactions as well as the alteration of their catalytic activities.